| 1 |
16940805 | Early destruction of tumor vasculature in tumor necrosis factor-alpha-based isolated limb perfusion is responsible for tumor response. | 2006 Sep |
3 |
| 2 |
15899822 | Synergistic antitumor response of interleukin 2 with melphalan in isolated limb perfusion in soft tissue sarcoma-bearing rats. | 2005 May 15 |
1 |
| 3 |
12094545 | Lack of cell-cycle specific effects of tumor necrosis factor-alpha on tumor cells in vitro: implications for combination tumor therapy with doxorubicin. | 2002 |
1 |
| 4 |
10916754 | Tumor necrosis factor-alpha augments tumor effects in isolated hepatic perfusion with melphalan in a rat sarcoma model. | 2000 Jul-Aug |
1 |
| 5 |
10956394 | Low-dose tumor necrosis factor-alpha augments antitumor activity of stealth liposomal doxorubicin (DOXIL) in soft tissue sarcoma-bearing rats. | 2000 Sep 15 |
1 |
| 6 |
10389992 | Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats. | 1999 Apr |
1 |
| 7 |
9733636 | Assessment of the role of neutrophils on the antitumor effect of TNFalpha in an in vivo isolated limb perfusion model in sarcoma-bearing brown Norway rats. | 1998 Aug |
1 |
| 8 |
8980389 | Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study. | 1996 Dec |
1 |
| 9 |
8038591 | Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study. | 1994 Mar |
1 |